Retinoblastoma (MSK, Cancers 2021)

Summary

Retinoblastoma (MSK, Cancers 2021) is a study catalogued by cBioPortal DataHub under the cancer-type code rbl. EvidenceHelix groups it with skin and eye studies.

Study description

Targeted sequencing of 83 Retinoblastoma tumor-normal pairs via MSK-IMPACT. Genomic data provided is limited to somatic alterations.

Text as published in the source's study metadata.

Citation & PubMed

Francis et al. Cancers 2021

Linked PubMed records: PMID 33466343

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

rbl_mskcc_2020

Short name

RBL (MSK, Cancers 2021)

Source cancer-type code

rbl

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Francis et al. Cancers 2021

• PubMed record 33466343 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Melanoma (MSK, Cell 2017) - iAtlas Harmonized

  Whole-exome sequencing and neoantigen landscape analysis of tumors from 64 advanced melanoma patients, profiled before and after nivolumab treatment. The reprocessing of raw sequencing data is coordinated by CRI iAtla…

  Skin and eyeMSK studiesSource code melPubMed 1

• Melanoma (MSK, Clin Cancer Res 2021)

  Targeted sequencing (MSK-IMPACT) of 696 melanoma tumor/normal pairs.

  Skin and eyeMSK studiesSource code melPubMed 1

• Melanoma (MSK, NEJM 2014)

  Whole-exome sequencing of 64 pretreated (ipilimumab or tremelimumab) melanoma tumor-normal pairs.

  Skin and eyeMSK studiesSource code skcmPubMed 1

• Metastatic Melanoma (MSK, JCO Precis Oncol 2017)

  Targeted sequencing of pre-treatment 66 Melanoma tumor samples. PubMed (https://ascopubs.org/doi/full/10.1200/PO.16.00054)

  Skin and eyeMSK studiesSource code skcmPubMed 1

• Acral Melanoma (TGEN, Genome Res 2017)

  Whole exome sequencing and transcriptome analysis of 34 Acral Melanoma patients (33 with matched normals).

  Skin and eyeOther published and consortium studiesSource code melPubMed 1

• Basal Cell Carcinoma (UNIGE, Nat Genet 2016)

  Whole-exome sequencing of 126 basal cell carcinoma tumor/normal pairs; targeted sequencing of 163 sporadic samples (40 tumor/normal pairs) and 4 Gorlin symdrome basal cell carcinomas.

  Skin and eyeOther published and consortium studiesSource code bccPubMed 1

• Cutaneous Squamous Cell Carcinoma (DFCI, Clin Cancer Res 2015)

  Targeted sequencing of 29 metastatic cutaneous squamous cell carcinoma samples.

  Skin and eyeOther published and consortium studiesSource code csccPubMed 1

• Cutaneous Squamous Cell Carcinoma (MD Anderson, Clin Cancer Res 2014)

  Whole-exome sequencing of tumor/normal pairs from 39 aggressive cutaneous squamous cell carcinoma cases.

  Skin and eyeOther published and consortium studiesSource code csccPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.